German CDMO Evotec is to acquire compatriot company Central Glass Germany from Japanese owner Central Glass for a nominal price of €1. The transaction, which remains...
26.10.2018
- East Rutherford, NJ/USA-based Cambrex Corporation is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its...
19.09.2018
- The topic of supply chain security is not a new one for the pharmaceutical industry, and much of that discussion has been dominated by the cGMP portion of the API supply chain. The...
13.12.2017
- PMC Group France, a wholly owned subsidiary of US-based PMC Group International, has acquired the pharmaceuticals business of France’s Isochem for an undisclosed sum. The business...
11.10.2017
- Swiss specialty chemicals company Lonza has acquired Shire’s clinical-stage mammalian manufacturing site in Hayward, California, USA, boosting its cGMP capacity and supplementing...
09.06.2017
- US active pharmaceutical ingredients (API) manufacturer Cambrex Corporation has announced the expansion of large-scale manufacturing capacity at its cGMP plant in Karlskoga, Sweden...
27.03.2017
- Umicore’s active pharmaceutical ingredients (API) facility in Pilar, Buenos Aires, successfully underwent a European cGMP inspection by the German Health and Medicine Authority...
05.10.2016
- US life sciences company Cambrex has completed and validated a new pilot plant at its manufacturing and R&D site in Paullo, Milan, Italy. Built to meet customer demand for small...
